Previously, Mr. Dimun has been a partner in a private equity group and in a large accounting firm. He has also served in directorship positions for medical device companies and has helped develop early stage device companies, according to the release.
He recently served as executive vice president and chief financial officer of Vital Signs, and grew the device company from $5 million to its ultimate sale to GE Medical for $900 million.
More Articles on Devices:
Biomet Gains Exclusive Distribution Rights to OPM OsteoFab Implants
13 Spine Devices Receive FDA 510(k) Clearance in March
5 Thoughts on Physician-Owned Distributorships
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
